ABLD — AbL Diagnostics SA Balance Sheet
0.000.00%
- €72.68m
- €74.44m
- €5.33m
Annual balance sheet for AbL Diagnostics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.36 | 2.7 | 1.03 | 2.23 | 0.529 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.015 | 0.011 | 4.93 | 4.31 | 3.45 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.38 | 2.71 | 12 | 11.6 | 8.43 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0 | 0.827 | 0.511 | 0.463 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.38 | 2.71 | 15.4 | 14.9 | 11.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.018 | 0.094 | 6.99 | 5.84 | 2.8 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.018 | 0.094 | 8.65 | 8.14 | 4.32 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.36 | 2.62 | 6.75 | 6.77 | 7.49 |
| Total Liabilities & Shareholders' Equity | 2.38 | 2.71 | 15.4 | 14.9 | 11.8 |
| Total Common Shares Outstanding |